CompaniesByCap
DCOY
Salarius Pharmaceuticals, Inc. (DCOY)
NASDAQ · Healthcare

Salarius Pharmaceuticals, Inc. Cash Flow 2015–2022

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Operating Activities
Operating Cash Flow-4.8M-4.5M-12.8M-17.6M-10.2M-10.3M-11.6M4.2M-27.7M-32.1M-20.7M
Depreciation & Amort.7,1514,42410,0516,67719,18318,058127,40816,950
Investing Activities
Capital Expenditure02,60000113,498559,378265,617
Free Cash Flow-10.2M-10.3M-11.6M4.2M-27.8M-32.6M-21.0M
Financing Activities
Dividends Paid0133,5940
Stock Buybacks

Salarius Pharmaceuticals, Inc. Cash Flow — FAQ

Salarius Pharmaceuticals, Inc. (DCOY) cash flow over the last 8 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see DCOY's cash flow history?

The chart and table above show Salarius Pharmaceuticals, Inc.'s cash flow by year and by quarter, including the growth rate.